Biomarker Blood Tests for Cerebral Palsy

  • Robert E. AkinsEmail author
  • Karyn G. Robinson
Living reference work entry


Together, the multiple types of cerebral palsy (CP) represent the most common physical disability in childhood with the spastic type accounting for ~77% of cases. CP arises with a disturbance in the brain, which in most cases occurs between 24 weeks gestation and birth. Early intervention is desirable, but early diagnosis is very challenging, and diagnosis is often delayed for several months or even years. No current molecular biomarker platform readily identifies individuals with CP, but screening assays that could measure blood biomarkers, preferably collected at the time of birth, may allow for earlier diagnosis, intervention, and the development of novel therapeutics. Biomarkers that identify CP patients are needed, and multiple efforts to identify useful biomarkers in blood samples are underway. It is important to understand the nature of diagnostic biomarkers and the types of blood biomarkers being investigated in individuals with CP.


Cerebral palsy Biomarker Blood test 


  1. Adams Waldorf KM, McAdams RM (2013) Influence of infection during pregnancy on fetal development. Reproduction 146:R151–R162. Scholar
  2. Bahrami A et al (2018) The prognostic and therapeutic application of microRNAs in breast cancer: tissue and circulating microRNAs. J Cell Physiol 233:774–786. Scholar
  3. Blaze J, Roth TL (2015) Evidence from clinical and animal model studies of the long-term and transgenerational impact of stress on DNA methylation. Semin Cell Dev Biol 43:76–84. Scholar
  4. Chapman S, Farina L, Kronforst K, Dizon M (2018) MicroRNA profile differences in neonates at risk for cerebral palsy. Phys Med Rehabil – Int 5:1148–1153Google Scholar
  5. Costantine MM et al (2011) Umbilical cord blood biomarkers of neurologic injury and the risk of cerebral palsy or infant death. Int J Dev Neurosci 29:917–922. Scholar
  6. Crowgey EL, Marsh AG, Robinson KG, Yeager SK, Akins RE (2018) Epigenetic machine learning: utilizing DNA methylation patterns to predict spastic cerebral palsy. BMC Bioinf 19:225. Scholar
  7. Data and Statistics | Cerebral Palsy | NCBDDD | CDC. (2017)Google Scholar
  8. Epigenetics and Public Health: Why we should pay attention. (2014).
  9. FDA-NIH Biomarker Working Group: BEST (Biomarkers, EndpointS, and other Tools) Resource. (2016)
  10. Gebert LFR, MacRae IJ (2018) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. Scholar
  11. Hadders-Algra M (2014) Early diagnosis and early intervention in cerebral palsy. Front Neurol 5:185. Scholar
  12. Hartley I et al (2013) Long-lasting changes in DNA methylation following short-term hypoxic exposure in primary hippocampal neuronal cultures. PLoS One 8:e77859. Scholar
  13. Houtepen LC et al (2016) Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans. Nat Commun 7:10967. Scholar
  14. Hubermann L, Boychuck Z, Shevell M, Majnemer A (2016) Age at referral of children for initial diagnosis of cerebral palsy and rehabilitation: current practices. J Child Neurol 31:364–369. Scholar
  15. Jiao Z et al (2017) Wholegenome scale identification of methylation markers specific for cerebral palsy in monozygotic discordant twins. Mol Med Rep 16:9423–9430. Scholar
  16. Jones MJ, Goodman SJ, Kobor MS (2015) DNA methylation and healthy human aging. Aging Cell 14:924–932. Scholar
  17. Joubert BR et al (2016) DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis. Am J Hum Genet 98:680–696. Scholar
  18. Key Findings: Birth Prevalence of Cerebral Palsy | Key Findings | Cerebral Palsy | NCBDDD | CDC. (2017)Google Scholar
  19. Labonte B et al (2012) Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry 69:722–731. Scholar
  20. MacLennan AH, Thompson SC, Gecz J (2015) Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol 213:779–788. Scholar
  21. Maitre NL, Slaughter JC, Aschner JL (2013) Early prediction of cerebral palsy after neonatal intensive care using motor development trajectories in infancy. Early Hum Dev 89:781–786. Scholar
  22. McIntyre S, Blair E, Badawi N, Keogh J, Nelson KB (2013) Antecedents of cerebral palsy and perinatal death in term and late preterm singletons. Obstet Gynecol 122:869–877. Scholar
  23. Mohandas N et al (2018) Epigenome-wide analysis in newborn blood spots from monozygotic twins discordant for cerebral palsy reveals consistent regional differences in DNA methylation. Clin Epigenetics 10:25. Scholar
  24. Nelson KB, Ellenberg JH (1986) Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 315:81–86. Scholar
  25. Pacis A et al (2015) Bacterial infection remodels the DNA methylation landscape of human dendritic cells. Genome Res 25:1801–1811. Scholar
  26. Palatnik A, Rouse DJ, Stamilio DM, McPherson JA, Grobman WA (2015) Association between cerebral palsy or death and umbilical cord blood magnesium concentration. Am J Perinatol 32:1263–1267. Scholar
  27. Rask-Andersen M et al (2016) Epigenome-wide association study reveals differential DNA methylation in individuals with a history of myocardial infarction. Hum Mol Genet.
  28. Smith ZD, Meissner A (2013) DNA methylation: roles in mammalian development. Nat Rev Genet 14:204–220. Scholar
  29. Sorokin Y et al (2014) Umbilical cord serum interleukin-6, C-reactive protein, and myeloperoxidase concentrations at birth and association with neonatal morbidities and long-term neurodevelopmental outcomes. Am J Perinatol 31:717–726. Scholar
  30. Spittle A, Orton J, Anderson PJ, Boyd R, Doyle LW (2015) Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants. Cochrane Database Syst Rev 11:CD005495. Scholar
  31. Stirzaker C et al (2015) Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value. Nat Commun 6:5899. Scholar
  32. Toffolo K et al (2018) Circulating microRNAs as biomarkers in traumatic brain injury. Neuropharmacology. Scholar
  33. Treiber T, Treiber N, Meister G (2018) Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. Scholar
  34. Varner MW et al (2015) The association of cord serum cytokines with neurodevelopmental outcomes. Am J Perinatol 30:115–122. Scholar
  35. Xiao X et al (2016) Fetal growth restriction and methylation of growth-related genes in the placenta. Epigenomics 8:33–42. Scholar
  36. Yuan Y (2017) Study of global DNA methylation in monozygotic twins with cerebral palsy. Pak J Pharm Sci 30:1467–1473PubMedGoogle Scholar
  37. Ziller MJ et al (2013) Charting a dynamic DNA methylation landscape of the human genome. Nature 500:477–481. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Nemours Biomedical ResearchNemours – Alfred I. duPont Hospital for ChildrenWilmingtonUSA

Section editors and affiliations

  • Steven J. Bachrach
    • 1
    • 2
  • Freeman Miller
    • 3
  1. 1.Department of Pediatrics (Emeritus)Nemours/Alfred I. duPont Hospital for ChildrenWilmingtonUSA
  2. 2.Sidney Kimmel Medical College of Thomas Jefferson UniversityPhiladelphiaUSA
  3. 3.AI DuPont Hospital for ChildrenWilmingtonUSA

Personalised recommendations